Association of Annual Operator Volume With the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention

Judit Karacsonyi, Ioannis Tsiafoutis, Khaldoon Alaswad

  • 1Red Cross General Hospital, 1 Athanasaki St, 11526, Athens, Greece. koutouzismike@yahoo.gr.

Insights

High-volume operators (HVOs) performing chronic total occlusion percutaneous coronary intervention (CTO-PCI) achieve higher success rates but also experience more complications. Operator volume significantly impacts CTO-PCI outcomes, with HVOs demonstrating better technical success despite increased lesion complexity.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Interventions
  • Vascular Medicine

Background:

  • Limited data exist on the relationship between operator volume and outcomes for chronic total occlusion percutaneous coronary intervention (CTO-PCI).
  • Understanding this association is crucial for optimizing patient care and procedural success in complex PCI cases.

Purpose of the Study:

  • To analyze the association between operator volume and procedural outcomes in a large cohort of CTO-PCI procedures.
  • To determine if higher operator volume correlates with improved technical success and complication rates in CTO-PCI.

Main Methods:

  • A multicenter registry analysis of 7035 CTO-PCIs performed between 2012 and February 2021.
  • Operators were categorized into low-volume (<30 cases/year), medium-volume (30-60 cases/year), and high-volume (>60 cases/year) groups.
  • Outcomes including technical success and periprocedural major adverse cardiac events were compared across volume groups, adjusting for lesion complexity.

Main Results:

  • High-volume operators (HVOs) performed procedures on more complex lesions, indicated by higher J-CTO scores and increased prevalence of proximal tortuosity and cap ambiguity.
  • Cases performed by HVOs demonstrated higher technical success rates (87.9%) compared to medium-volume (86.9%) and low-volume operators (82.6%).
  • HVOs also had higher rates of periprocedural major cardiac adverse events (3.08%) versus MVOs (2.71%) and LVOs (1.50%).

Conclusions:

  • A significant proportion of CTO-PCI cases (40%) are performed by low-volume operators.
  • While HVOs achieve superior technical success in CTO-PCI, this is associated with a higher incidence of periprocedural complications, likely due to managing more complex cases.
  • Operator experience and case volume are critical factors influencing CTO-PCI outcomes, necessitating further investigation into strategies for improving results across all operator levels.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
28
Cardiac Output and Stroke Volume01:11

Cardiac Output and Stroke Volume

Cardiac output (CO) is an integral aspect of human physiology, reflecting the heart's efficiency and responsiveness to the body's needs. It represents the volume of blood that the left or right ventricle ejects into the aorta or pulmonary trunk each minute. The CO is calculated by multiplying the heart rate (HR)—the number of heartbeats per minute—by the stroke volume (SV)—the amount of blood pumped out with each heartbeat.
In an average resting adult male, the typical cardiac...
3.2K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
24
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
1.3K